谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

LBA4 Adjuvant Nivolumab Plus Ipilimumab (NIVO+IPI) Vs Placebo (PBO) for Localized Renal Cell Carcinoma (RCC) at High Risk of Relapse after Nephrectomy: Results from the Randomized, Phase III CheckMate 914 Trial

R.J. Motzer,P. Russo,V. Gruenwald,Y. Tomita,B. Zurawski,O.A. Parikh,S. Buti,P. Barthelemy,J.C.H. Goh,D. Ye,A. Lingua,J-B. Lattouf,B. Escudier,S. George,B. Shuch,B. Simsek, J. Spiridigliozzi,A. Chudnovsky,A. Bex

Annals of Oncology（2022）

引用 28|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要